Upcoming Webinar

The JPM “Post-Conference”: Medtech Insights and 2023 Expectations

Date: Tuesday, February 7, 2023
Time: 2:00PM ET / 11:00AM PT
Moderator:
Lynn Pieper Lewis
Founder & CEO, Gilmartin Group

Speakers:
Annie Wernig,
Managing Director,
Healthcare Investment Banking,
J.P. Morgan

Benjamin Burdett,
Managing Director,
Healthcare Equity Capital Markets,
J.P. Morgan

The JPM “Post-Conference”: Medtech Insights and 2023 Expectations

2023 was the first in-person J.P. Morgan Conference in recent years and San Francisco welcomed the healthcare community back with open arms. In this webinar, we’ll be taking a deeper dive into the trends and insights that emerged from the conference with the hosts of the main event, J.P. Morgan.


Featured Speakers

Annie Wernig
Managing Director, Healthcare Investment Banking, J.P, Morgan

Read Biography

Annie Wernig is a Managing Director in J.P. Morgan’s Healthcare Investment Banking Group, focused on the Medical Device sector. Annie joined J.P. Morgan in 2013 and has primarily covered the medtech landscape since then. She advises clients across M&A and capital raising transactions, including private placements, IPOs and follow-on offerings as well as debt offerings. She holds a B.A. in Economics from Princeton University and an MBA from the University of Virginia’s Darden School of Business.

Benjamin Burdett
Managing Director, Healthcare Equity Capital Markets, J.P, Morgan

Read Biography

Annie Wernig is a Managing Director in J.P. Morgan’s Healthcare Investment Banking Group, focused on the Medical Device sector. Annie joined J.P. Morgan in 2013 and has primarily covered the medtech landscape since then. She advises clients across M&A and capital raising transactions, including private placements, IPOs and follow-on offerings as well as debt offerings. She holds a B.A. in Economics from Princeton University and an MBA from the University of Virginia’s Darden School of Business.

Moderator


webinar-mod-bio-pic

Lynn Pieper Lewis
Founder & CEO, Gilmartin Group

Read Biography

Lynn founded Gilmartin Group with the belief that companies deserve better advice. She has spent the bulk of her career on Wall Street, accumulating 20 years of experience writing research, analyzing and advising entities in the healthcare industry. Having created and executed investor relations programs and strategies for over 50 companies at various stages of development, Lynn has a proven track record of success.

gilmartin-logo

Our Clients

Our clients are leaders and innovators across the MedTech, Biotechnology, Digital Health, Life Science Tools & Diagnostic sectors

Learn More About Our Clients

Resources

Gilmartin has a number of resources, from blog posts to webinars designed to educate and help your company achieve success.

Explore Resources